Department of Radiology

Publications

2023

Kim SH, Chang SJ, Dobri G, Strauss S, Lin E, Zavaletta V, et al. [68 Ga]-DOTATATE PET/MR-based evaluation of physiologic somatostatin receptor 2 expression in the adult pituitary gland as a function of age and sex in a prospective cohort. Pituitary. 2023;26(4):419-428.

Chung SK, Vargas DB, Chandler CS, Katugampola S, Veach DR, McDevitt MR, et al. Efficacy of HER2-Targeted Intraperitoneal 225Ac α-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal Carcinomatosis. J Nucl Med. 2023;64(9):1439-1445.

Bae J, Li C, Masurkar A, Ge Y, Kim SG. Improving measurement of blood-brain barrier permeability with reduced scan time using deep-learning-derived capillary input function. Neuroimage. 2023;278:120284.

Abdel-Rahman SA, Świderek K, Gabr MT. First-in-class small molecule inhibitors of ICOS/ICOSL interaction as a novel class of immunomodulators. RSC Med Chem. 2023;14(9):1767-1777.

Bojesen KB, Rostrup E, Sigvard AK, Mikkelsen M, Edden RA, Ebdrup BH, et al. The Trajectory of Prefrontal GABA levels in Initially Antipsychotic-Naïve Patients with Psychosis during Two Years Treatment and associations with Striatal Cerebral Blood Flow and Outcome. Biol Psychiatry Cogn Neurosci Neuroimaging. 2023.

Schiff ND, Giacino JT, Butson CR, Choi EY, Baker JL, O'Sullivan KP, et al. Thalamic deep brain stimulation in traumatic brain injury: a phase 1, randomized feasibility study. Nat Med. 2023;29(12):3162-3174.

Webster EM, Ahsan MD, Perez L, Levi SR, Thomas C, Christos P, et al. Chatbot Artificial Intelligence for Genetic Cancer Risk Assessment and Counseling: A Systematic Review and Meta-Analysis. JCO Clin Cancer Inform. 2023;7:e2300123.

Chaudhry H, Rana S, Bhatti MI, Al-Ansari N, Theyab AA, Almutairi T, et al. Utility of the Anatomage Virtual Dissection Table in Creating Clinical Anatomy and Radiology Learning Modules. Adv Med Educ Pract. 2023;14:973-981.

Guernsey E, Babagbemi K. Patient-Friendly Summary of the ACR Appropriateness Criteria®: Dyspnea-Suspected Cardiac Origin (Ischemia Already Excluded). J Am Coll Radiol. 2023;20(8):e33.

Chernov V, Rybina A, Zelchan R, Medvedeva A, Bragina O, Lushnikova N, et al. Phase I Trial of [99mTc]Tc-maSSS-PEG2-RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors. Cancers (Basel). 2023;15(6).